FDAnews
www.fdanews.com/articles/81268-generex-biotechnology-initiates-scale-up-commercial-production-run-of-oral-lyn

GENEREX BIOTECHNOLOGY INITIATES SCALE-UP COMMERCIAL PRODUCTION RUN OF ORAL-LYN

September 29, 2005

Generex Biotechnology Corporation (Nasdaq: GNBT), a leader in the area of buccal drug delivery, announced today that it has initiated a scale-up commercial production run of Oral-lyn(TM), the Company's proprietary oral insulin buccal spray product. Earlier this week Generex commenced filling several thousand canisters of Oral-lyn(TM) at its pilot production facilities in Toronto, Canada in order to validate the equipment for technology transfer to the facilities of the Company's South American joint venture partner, PharmaBrand, S.A. (http://www.pharmabrand.com.ec (http://www.pharmabrand.com.ec)), in Quito, Ecuador.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/09-29-2005/0004134723&EDATE=)